Showing results (1-10 of 1,105) with videos related to
Sort By:
Pageof 111
Trends in Molecular Medicine|July 26, 2025
Host-microbe interactions in NAD+ metabolismXiaoyue Wu, Igor Shats, Xiaoling LiBMC Genomics|April 16, 2021
Predicting tumor response to drugs based on gene-expression biomarkers of sensitivity learned from cancer cell linesYuanyuan Li, David M Umbach, Juno M Krahn, et al.Plos Computational Biology|December 3, 2019
CDSeq: A novel complete deconvolution method for dissecting heterogeneous samples using gene expression dataKai Kang, Qian Meng, Igor Shats, et al.Plos One|June 15, 2019
Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanomaYuanyuan Li, Melissa Li, Igor Shats, et al.EMBO Reports|March 14, 2026
Paneth cell SIRT1 deficiency increases intestinal stress resistance by modulating the gut microbiotaLiz M Garcia-Peterson, Alicia S Wellman, Xiaojiang Xu, et al.FEBS Letters|July 2, 2003
The murine telomerase catalytic subunit shares the PAb-240 mutant specific epitope of the p53 proteinIgor Shats, Michael Milyavsky, Neta Erez, et al.Oncotarget|July 30, 2015
p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathwaysMaria Shatz, Igor Shats, Daniel Menendez, et al.Plos One|June 4, 2015
E2F1-Mediated Induction of NFYB Attenuates Apoptosis via Joint Regulation of a Pro-Survival Transcriptional ProgramXiaolei Jiang, Joseph Roy Nevins, Igor Shats, et al.Cell Cycle (Georgetown, Tex.)|May 15, 2007
Myocardin in tumor suppression and myofibroblast differentiationIgor Shats, Michael Milyavsky, Alina Cholostoy, et al.Cancer Research|December 26, 2003
Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growthNeta Erez, Michael Milyavsky, Raya Eilam, et al.Pageof 111